Cargando…
Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
Exogenous supplement of recombinant human (rh)ACE-2 might be a brilliant idea in the treatment of COVID-19. Soluble ACE-2 might impact viral spread, since binding to soluble receptor has been shown to block SARS-CoV-2 entry. https://bit.ly/3bsUKO2
Autor principal: | Lutchman, Dhamend |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236827/ https://www.ncbi.nlm.nih.gov/pubmed/32398309 http://dx.doi.org/10.1183/13993003.01560-2020 |
Ejemplares similares
-
Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020) -
COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020) -
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020) -
Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020) -
mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19
por: Tang, Yan, et al.
Publicado: (2021)